Posts with tag: technology
CVS Q4 2024 Earnings Beat Estimates, Stock Up; Revenue Rises, Profits Decline
Published on: February 12, 2025, 06:03 PM UTC
Inflation stays hotter than expected, makes Fed rate cuts less likely this year
Published on: February 12, 2025, 06:02 PM UTC
Trump calls out "Biden inflation" as January consumer prices rise more than expected, pushing down probabilities of another Fed cut.
Published on: February 12, 2025, 06:02 PM UTC
Intel's stock surged after VP Vance promoted domestic chip manufacturing, highlighting the company's role as a leading US hope for AI chip production despite facing challenges and internal issues.
Published on: February 12, 2025, 06:02 PM UTC
U.S. manufacturers face uncertainty as Trump's trade policies raise costs and cast a shadow over domestic manufacturing recovery.
Published on: February 12, 2025, 06:01 PM UTC
3 healthcare stocks facing challenges: Repligen (RGEN), Thermo Fisher (TMO), and Danaher (DHR). Learn why their sales, margins, and growth prospects are concerning.
Published on: February 12, 2025, 05:06 PM UTC
Oracle Co-founder Larry Ellison says governments should consolidate national data for AI models. He claims that unifying data sets can improve public services, reduce costs, and prevent fraud.
Published on: February 12, 2025, 05:06 PM UTC
Price growth unexpectedly spiked in January, reaching 3.3% over the past 12 months, exceeding expectations and posing a challenge to President Trump's economic agenda. Despite Trump's campaign promise to lower prices immediately, data shows slowing price growth may be more difficult than anticipated.
Published on: February 12, 2025, 05:05 PM UTC
Bond traders defer interest rate cut expectations to December as US inflation surpasses forecasts.
Published on: February 12, 2025, 05:04 PM UTC
CVS (CVS) reported Q4 and FY24 earnings, beating estimates and sending shares up 8% pre-market. Revenue was $372.8B for the year and $97.7B for Q4, beating estimates of $96.8B. The healthcare benefits segment saw a slight decline due to Medicare and Medicaid headwinds, while the retail pharmaceutical and healthcare services segments increased. Despite a challenging year and ongoing government headwinds, CVS remains the largest PBM and provided 2025 guidance with adjusted EPS of $5.75-$6.00.
Published on: February 12, 2025, 05:03 PM UTC